Galmed Pharmaceuticals (GLMD) Operating Expenses (2013 - 2026)
Galmed Pharmaceuticals (GLMD) posted quarterly Operating Expenses of $2.0 million for Q1 2026, up 61.71% year-over-year from $1.3 million in Q1 2025, and down 32.81% quarter-over-quarter from $3.0 million in Q4 2025.
Galmed Pharmaceuticals (GLMD) Operating Expenses (2013 - 2026) Analysis & Trends
Galmed Pharmaceuticals' Operating Expenses history runs 14 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 61.71% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $9.3 million (up 51.28% YoY), while the FY2025 annual figure was $8.5 million, up 35.55% from the prior year.
- Operating Expenses for Q1 2026 stood at $2.0 million, down from $3.0 million in the prior quarter.
- The five-year high for Operating Expenses was $5.4 million in Q3 2022, with the low at -$250000.0 in Q1 2022.
- The 5-year median for Operating Expenses is $2.0 million (2024), against an average of $2.1 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses tumbled 102.74% in 2022, then surged 900.8% in 2023.
- Galmed Pharmaceuticals' Operating Expenses stood at $2.4 million in 2022, then slipped by 12.17% to $2.2 million in 2023, then dropped by 23.57% to $1.6 million in 2024, then soared by 85.04% to $3.0 million in 2025, then slumped by 32.81% to $2.0 million in 2026.
- Business Quant data shows GLMD's Operating Expenses at $2.0 million in Q1 2026, $3.0 million in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Galmed Pharmaceuticals | 2.39 Mn | -9.49 Mn | - | 2.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 3.04 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 2.11 Mn |
| Mar 31, 2025 | 1.26 Mn |
| Dec 31, 2024 | 1.64 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | 1.22 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 2.15 Mn |
| Sep 30, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 2.45 Mn |
| Sep 30, 2022 | 5.38 Mn |
| Jun 30, 2022 | 3.73 Mn |
| Mar 31, 2022 | -250,000.00 |
| Dec 31, 2021 | 7.49 Mn |
| Sep 30, 2021 | 7.85 Mn |
| Jun 30, 2021 | 8.41 Mn |